Abstract
Mycosis fungoides (MF), a cutaneous T-cell lymphoma, is usually characterized by cell features of T-helper-2 (Th2) lymphocytes. MF has recently been reported to show increased CCR4 expression, a chemokine receptor specifically expressed in Th2. Previously, we have reported the effectiveness of interferon-gamma (IFN-gamma) for the treatment of CCR4(+) MF. In this report, we describe two cases of CD4(+), CCR4(-) MF successfully treated with IFN-alpha, but not IFN-gamma. Although MF usually displays a Th2 profile, the tumor cells in our two cases did not express CCR4. Our cases suggest the effectiveness of IFN-alpha, but not IFN-gamma, for CCR4- MF.
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use*
-
CD4-Positive T-Lymphocytes / metabolism
-
Diagnosis, Differential
-
Erythema / etiology
-
Humans
-
Injections, Subcutaneous
-
Interferon-alpha / administration & dosage
-
Interferon-alpha / therapeutic use*
-
Male
-
Middle Aged
-
Mycosis Fungoides / blood
-
Mycosis Fungoides / complications
-
Mycosis Fungoides / diagnosis*
-
Mycosis Fungoides / drug therapy*
-
Mycosis Fungoides / metabolism
-
Mycosis Fungoides / pathology
-
Receptors, CCR4
-
Receptors, Chemokine / metabolism
Substances
-
Antineoplastic Agents
-
CCR4 protein, human
-
Interferon-alpha
-
Receptors, CCR4
-
Receptors, Chemokine